In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
RAVEN BIOTECHNOLOGIES ADVANCES RAV18 THROUGH AGREEMENT WITH CMC ICOS BIOLOGICS
Lilly announces amendment to merger agreement with ICOS
Celera Genomics and Seattle Genetics announce target selection from research collaboration in cancer
Seattle Genetics Announces Manufacturing Agreement with Abbott Laboratories
Genentech ends Seattle Genetics licensing pact
Seattle Genetics Announces Antibody-Drug Conjugate Agreement with Bayer Pharmaceuticals
ICOS Corporation And Caprion Pharmaceuticals Enter Into Joint Development Collaboration
Seattle Genetics and PSMA development company announce antibody-drug conjugate collaboration
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
